118 related articles for article (PubMed ID: 3753798)
1. Pharmacology of erythromycin in infants and children.
Ginsburg CM
Pediatr Infect Dis; 1986; 5(1):124-9. PubMed ID: 3753798
[No Abstract] [Full Text] [Related]
2. Pharmacology of erythromycin in adults.
Griffith RS
Pediatr Infect Dis; 1986; 5(1):130-40. PubMed ID: 3511455
[No Abstract] [Full Text] [Related]
3. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
Ginsburg CM; McCracken GH; Culbertson MC
J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability.
McCracken GH; Ginsburg CM; Clahsen JC; Thomas ML
Pediatrics; 1978 Nov; 62(5):738-43. PubMed ID: 581516
[TBL] [Abstract][Full Text] [Related]
7. The penetration of erythromycin into Waldeyer's ring--tonsil and adenoid tissue.
Sundberg L; Edén T; Ernstson S
Infection; 1982; 10 Suppl 2():S105-7. PubMed ID: 6980840
[TBL] [Abstract][Full Text] [Related]
8. Plasma and salivary concentrations of erythromycin after administration of three different formulations.
Henry J; Turner P; Garland M; Esmieu F
Postgrad Med J; 1980 Oct; 56(660):707-10. PubMed ID: 7220406
[TBL] [Abstract][Full Text] [Related]
9. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
[No Abstract] [Full Text] [Related]
10. Penetration of erythromycin into tonsillar tissue.
Falchi M; Teodori F; Carraro A; Cioce C; Scaglione F; Braga PC; Fraschini F
Curr Med Res Opin; 1985; 9(9):611-5. PubMed ID: 4053675
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of doxycycline and erythromycin concentrations in the palatine tonsils].
Miniti A; Butugan O; Paiva LJ
Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(6):371-8. PubMed ID: 5496438
[No Abstract] [Full Text] [Related]
12. Comparison of erythromycin ethyl succinate, stearate and estolate treatments of group A streptococcal infections of the upper respiratory tract.
Janicki RS; Garnham JC; Worland MC; Grundy WE; Thomas JR
Clin Pediatr (Phila); 1975 Dec; 14(12):1098-107. PubMed ID: 1104241
[TBL] [Abstract][Full Text] [Related]
13. Selection of an oral erythromycin product.
Fraser DG
Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
[TBL] [Abstract][Full Text] [Related]
14. Erythromycin in the aqueous. Comparative concentrations form the estolate and from the base.
Nolan J; Lyle WH
Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):338-40. PubMed ID: 797069
[No Abstract] [Full Text] [Related]
15. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
[TBL] [Abstract][Full Text] [Related]
16. Persistence of inclusion conjunctivitis after oral erythromycin therapy.
Laperrière H; Lefebvre J
CMAJ; 1988 Nov; 139(9):875. PubMed ID: 3179892
[No Abstract] [Full Text] [Related]
17. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V.
Breese BB; Disney FA; Green JL; Talpey WB
Clin Pediatr (Phila); 1977 May; 16(5):460-3. PubMed ID: 403044
[No Abstract] [Full Text] [Related]
18. Topical sulfacetamide vs oral erythromycin for neonatal chlamydial conjunctivitis.
Heggie AD; Jaffe AC; Stuart LA; Thombre PS; Sorensen RU
Am J Dis Child; 1985 Jun; 139(6):564-6. PubMed ID: 3890519
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of antimicrobial agents in middle ear fluid, saliva and tears.
Nelson JD; Ginsburg CM; Mcleland O; Clahsen J; Culbertson MC; Carder H
Int J Pediatr Otorhinolaryngol; 1981 Dec; 3(4):327-34. PubMed ID: 6799415
[TBL] [Abstract][Full Text] [Related]
20. Risk-benefit equation for erythromycin estolate.
LeBel M
Am J Hosp Pharm; 1980 Feb; 37(2):176, 180. PubMed ID: 7361788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
